Screener
Alnylam Pharmaceuticals ALNY Current ratio
Current ratio at other companies
Other financials
Where this comes from
Calculated from Alnylam Pharmaceuticals’s reported figures.
Based on the most recent quarter.
The source filing: Alnylam Pharmaceuticals’s 10-Q, filed July 30, 2026. Open the filing →
- Filed
- Jul 30, 2026, 8:11 AM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001178670-26-000062
FAQ
- What is Alnylam Pharmaceuticals's current ratio?
- Alnylam Pharmaceuticals (ALNY) reported current ratio of 3.1× in Q2 2026.
- How has Alnylam Pharmaceuticals's current ratio changed year-over-year?
- Alnylam Pharmaceuticals's current ratio increased by 9.1% year-over-year, from 2.8× to 3.1×.
- What is the long-term trend for Alnylam Pharmaceuticals's current ratio?
- Over 5 years (2020 to 2025), Alnylam Pharmaceuticals's current ratio has grown at a -9.2% compound annual growth rate (CAGR), from 4.5× to 2.8×.
- What does current ratio mean?
- Current assets divided by current liabilities at the quarter end. Measures the company's ability to cover near-term obligations with near-term assets.
Ask your AI about Alnylam Pharmaceuticals's current ratio.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude